Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Non-small Cell Lung Cancer Stage IIIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00321334
What this trial is testing

Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC

Who this might be right for
Non-small Cell Lung Cancer
Chinese Society of Lung Cancer 410
Large-scale testing (Phase 3)Active Not RecruitingNCT04428905
What this trial is testing

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage I Colorectal Cancer AJCC v8Stage I Lung Cancer AJCC v8+19 more
City of Hope Medical Center 403
Testing effectiveness (Phase 2)UnknownNCT04040361
What this trial is testing

Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY)

Who this might be right for
Non-small Cell Lung Cancer Stage IBNon-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage ⅢA
Masahiro Tsuboi 24
Early research (Phase 1)Study completedNCT02364609
What this trial is testing

Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more
Jonathan Riess 11
Early research (Phase 1)Active Not RecruitingNCT05166616
What this trial is testing

Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaLocally Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more
City of Hope Medical Center 8
Large-scale testing (Phase 3)Active Not RecruitingNCT02511106
What this trial is testing

AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.

Who this might be right for
Stage IB-IIIA Non-small Cell Lung Carcinoma
AstraZeneca 682
Large-scale testing (Phase 3)Ended earlyNCT00113386
What this trial is testing

Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 19
Large-scale testing (Phase 3)Study completedNCT01134861
What this trial is testing

Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 610
Testing effectiveness (Phase 2)Study completedNCT03086733
What this trial is testing

Phase II Lung Metcore - Preoperative Metformin for Lung Cancer

Who this might be right for
Non Small Cell Lung CancerLung Cancer
University Health Network, Toronto 28
Testing effectiveness (Phase 2)Study completedNCT00004160
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Who this might be right for
Lung Cancer
University of Alabama at Birmingham 72
Large-scale testing (Phase 3)Ended earlyNCT00004859
What this trial is testing

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Institute (NCI) 589
Not applicableStudy completedNCT02819024
What this trial is testing

Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more
Barbara Ann Karmanos Cancer Institute 6
Testing effectiveness (Phase 2)WithdrawnNCT05022394
What this trial is testing

Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study

Who this might be right for
Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8+10 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00478699
What this trial is testing

Randomized Customized Adjuvant Chemotherapy (GECP-SCAT)

Who this might be right for
Non-small-cell Lung Cancer
Spanish Lung Cancer Group 500
Not applicableNot Yet RecruitingNCT06856798
What this trial is testing

Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: A Multi - Omics Perspective

Who this might be right for
NSCLC Stage IIIA/BNSCLC Stage II
Ziming Li 120
Testing effectiveness (Phase 2)Study completedNCT04205552
What this trial is testing

Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients

Who this might be right for
NSCLC Stage IINSCLC, Stage IIIANSCLC, Stage I
University Hospital, Essen 90
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Large-scale testing (Phase 3)Study completedNCT00172042
What this trial is testing

Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small-Cell Lung Cancer
Novartis Pharmaceuticals 437
Testing effectiveness (Phase 2)Study completedNCT00003269
What this trial is testing

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganLung Cancer+3 more
Scripps Health 20
Early research (Phase 1)WithdrawnNCT02059967
What this trial is testing

Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC

Who this might be right for
Adenocarcinoma of the LungLarge Cell Lung CancerSquamous Cell Lung Cancer+4 more
Virginia Commonwealth University
Next Page